Ascendia Pharmaceutical Solutions will be exhibiting at CPHI Americas 2025 from May 20–22 at the Pennsylvania Convention Center in Philadelphia. The event connects leaders from the pharmaceutical development and manufacturing sectors for three days of networking, technology showcases, and partnering opportunities.
Click here to schedule a meeting with Ascendia’s team at CPHI Americas.
Specialized Expertise in Complex Formulation Development
Ascendia is a specialty CDMO focused on solving drug delivery challenges for complex molecules. The company develops enabling formulations for poorly water-soluble compounds, sterile and non-sterile injectables, and controlled release systems. Its proprietary technologies—NanoSol®, AmorSol®, EmulSol®, and LipidSol™—enable sponsors to address solubility, stability, and bioavailability issues in both small and large molecules.
Flexible and Agile Partner for Emerging and Established Biopharma
Ascendia supports a broad range of clients, including emerging biotechs and mid-sized pharmaceutical firms. The company’s operating model is designed for flexibility and speed, offering tailored solutions without the constraints of large CDMO structures. Dedicated teams work collaboratively with clients to advance programs from early development through clinical trial supply and scale-up.
End-to-End Drug Development Capabilities
From preformulation and analytical method development to clinical manufacturing and aseptic fill-finish, Ascendia offers integrated services under one roof. The company’s 60,000-square-foot cGMP facility is equipped for oral, injectable, and ophthalmic dosage forms. Its track record includes over 500 formulation projects and support for multiple IND, NDA, and ANDA submissions.
Committed to Science-Driven Results and Transparent Communication
Ascendia operates with a science-first mindset, applying deep formulation expertise and innovative technologies to de-risk development. Clients benefit from transparent communication, direct access to senior scientists, and fast decision-making. Every program is supported by a cross-functional team aligned with sponsor goals, timelines, and regulatory requirements.
Schedule a Meeting with Ascendia at Booth #1517
Ascendia Pharmaceutical Solutions will be located at Booth #1517 throughout the conference. Pharmaceutical companies looking to advance their formulation development programs or address drug delivery challenges are encouraged to contact Ascendia to schedule a dedicated meeting at the event.
Click here to schedule a meeting with Ascendia’s team at CPHI Americas.